(Q47859067)

6 February 2018

title

Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet's Disease (English)

1 reference

6 February 2018

0 references

1 reference

12

1 reference

6 February 2018

Claudia Fabiani

Claudia Fabiani

1

0 references

Giacomo Emmi

Giacomo Emmi

5

0 references

Mauro Galeazzi

10

Mauro Galeazzi

1 reference

6 February 2018

2

Jurgen Sota

1 reference

6 February 2018

Bruno Frediani

9

Bruno Frediani

1 reference

6 February 2018

Gian Marco Tosi

11

Gian Marco Tosi

1 reference

6 February 2018

Lorenzo Vannozzi

6

Lorenzo Vannozzi

1 reference

6 February 2018

Daniela Bacherini

8

Daniela Bacherini

1 reference

6 February 2018

Donato Rigante

3

Donato Rigante

1 reference

6 February 2018

author name string

Antonio Vitale

4

1 reference

6 February 2018

Rossella Franceschini

7

1 reference

6 February 2018

publication date

5 October 2017

1 reference

6 February 2018

Ocular Immunology and Inflammation

published in

1 reference

6 February 2018

page(s)

1-6

1 reference

6 February 2018

Uveitis in Behçet disease: an analysis of 880 patients.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

Controversies in Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

Quality of life impairment in Behçet's disease and relationship with disease activity: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

EULAR recommendations for the management of Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

Adalimumab effectiveness in Behçet's disease: short and long-term data from a multicenter retrospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

Validation of the revised International Criteria for Behcet's Disease (ICBD) in Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

Cross-cultural adaptation of the Behçet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

Behçet Disease-associated Uveitis Successfully Treated with Golimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2017.1351573

10.1080/09273948.2017.1351573

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

28981395

1 reference

6 February 2018